Dai Lu

Title: Innovations by Inventor Dai Lu

Introduction

Dai Lu is a notable inventor based in Pearland, Texas, who has made significant contributions to the field of medical research. He holds two patents that focus on innovative methods for detecting and treating leukemia, particularly those associated with the Philadelphia chromosome.

Latest Patents

Dai Lu's latest patents include "BCR-ABL directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth." This invention provides methods for detecting and quantifying BCR-ABL gene products and other abnormal ABL gene products in Ph-positive leukemic cells. It also offers methods for assessing the tumor burden of a patient by determining the relative number of leukemic cells compared to normal ABL cells. Another significant patent is "Bcr-Abl directed compositions and uses for inhibiting Philadelphia," which discloses compositions comprising a mixture of peptides that bind to molecules involved in Bcr-Abl oncoprotein function. These peptides inhibit Bcr-Abl oncoprotein activation and block the oncogenic signal generated by the Bcr-Abl oncoprotein, thereby inducing cell death in leukemia cells expressing the oncoprotein.

Career Highlights

Dai Lu is affiliated with the University of Texas System, where he continues to advance his research and innovations in the medical field. His work has the potential to significantly impact the treatment of various types of leukemia, including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML).

Collaborations

Dai Lu has collaborated with notable colleagues such as Ralph B. Arlinghaus and Jiaxin Liu, contributing to the advancement of research in leukemia treatment.

Conclusion

Dai Lu's innovative work in the field of leukemia research exemplifies the importance of scientific advancements in improving patient outcomes. His patents reflect a commitment to developing effective therapies for challenging medical conditions.